Demand for protein foods grows

Busy mothers and time-poor executives are likely buyers

Protein supplements leap in popularity

Business people use shakes to balance diets and boost energy

Nestlé to aid pregnancy diet research

Study on role played by food eaten on the metabolism of babies

Big pharma cashes in on M&A fever

Promising signs from companies’ drug development pipelines

NHS launches genetic sequencing centres

Clinics aim to recruit 100,000 with rare diseases or cancer

Drugmaker Hikma eyes up acquisitions

Group seeking good targets at a reasonable price

Roche suffers double blow in drug trials

Shares drop amid breast cancer and Alzheimer’s setback

Judgment opens way for stem-cell patents

Lawyers describe EU court ruling as boost for medical research

BTG May 2006.Dr Louise Makin

BTG’s Makin transforms fast-growing group

UK healthcare company focuses on buying in specialist treatments

A woman uses a Philips radiology machine

Philips to buy US medical devices group

Dutch company bulks up healthcare business ahead of split

Juno IPO highlights latest buzz in US biotech

Cell therapy specialist poised for listing as sector draws investors

Cancer trial successes fuel investment

Adaptimmune flags potential to treat broad range of tumours

The Cancer Drugs Fund is a costly mistake

Labour compounds error in backing treatment with marginal benefit

Bayer fails to block cheap Indian drug

Indian Supreme Court rejects German pharma group’s appeal

Merck’s Ebola vaccine trial suspended

Setback as US nurse is latest to be exposed to virus

Drug resistance to cost $100tn by 2050

UK review urges global action to tackle threat

Surgeons turn to 3D and nanorobots to enhance human judgment and skill

Modern developments are helping transform operating procedures and their results

Signs of a revival in drug development

US approvals of new medicines show significant increase

Systems grapple with information deluge

How to harness resources to patients’ advantage is one of the sector’s big challenges

India in frontline in battle over IP rights

Rulings on patents emerge as a significant source of friction between New Delhi and the US


More FT Twitter accounts